John L Law

This inventor holds 12 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: University of Alberta, Helmholtz Center for Infection Research. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John L Law. Retrieved from https://idiyas.com/inventor/john-l-law

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 2 (Patent Applications = 10)

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 6(Granted Patents)

Company Filing History:

12 out of 455

University of Alberta

patents

2 out of 2

Helmholtz Center for Infection Research

patents

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12296005 - Hepatitis C virus immunogenic compositions and methods of use thereof (2025-05-13),

2. 12202859 - Hepatitis c virus E1/E2 heterodimers and methods of producing same (2025-01-21),

3. 12048742 - Hepatitis C virus peptide compositions and methods of use thereof (2024-07-30),

4. 12042536 - Hepatitis C virus immunogenic compositions and methods of use thereof (2024-07-23),

5. 12005116 - Hepatitis C virus immunogenic compositions and methods of use thereof (2024-06-11),

6. 11576968 - Hepatitis C virus immunogenic compositions and methods of use thereof (2023-02-14),

7. 11576967 - Hepatitis C virus immunogenic compositions and methods of use thereof (2023-02-14),

8. 11324818 - Hepatitis c virus immunogenic compositions and methods of use thereof (2022-05-10),

9. 11186615 - Hepatitis C virus E1/E2 heterodimers and methods of producing same (2021-11-30),

10. 10881727 - Hepatitis C virus immunogenic compositions and methods of use thereof (2021-01-05),

11. 10881726 - Hepatitis C virus immunogenic compositions and methods of use thereof (2021-01-05),

12. 10300131 - Hepatitis C virus immunogenic compositions and methods of use thereof (2019-05-28),

Title: John L Law: Innovator in Hepatitis C Research

Introduction

John L Law is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of medical research, particularly in the development of immunogenic compositions for the hepatitis C virus. With a total of 12 patents to his name, Law's work has the potential to impact the treatment and prevention of hepatitis C.

Latest Patents

Among his latest patents, Law has developed immunogenic compositions that include a hepatitis C virus (HCV) heterodimeric polypeptide comprising HCV E1 and E2 polypeptides. These compositions aim to induce an immune response in individuals against HCV. Additionally, he has worked on affinity tagged heterodimeric polypeptides that facilitate the production of HCV E1/E2 heterodimers, which are crucial for advancing vaccine development.

Career Highlights

Law has had a distinguished career, working with esteemed institutions such as the University of Alberta and the Helmholtz Center for Infection Research. His research has focused on innovative methods to combat hepatitis C, showcasing his dedication to improving public health through scientific advancements.

Collaborations

Throughout his career, Law has collaborated with notable scientists, including Michael Houghton and Michael Logan. These partnerships have further enriched his research and contributed to the development of effective solutions for hepatitis C.

Conclusion

John L Law's innovative work in hepatitis C research exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for advancements in treatment and prevention strategies.

Profile summary based on public USPTO records.